Detalhe da pesquisa
1.
Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability.
Mol Cell
; 54(3): 445-59, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24746700
2.
NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer.
BMC Cancer
; 19(1): 236, 2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935371
3.
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
Lab Invest
; 98(1): 15-26, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29251737
4.
Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study.
Br J Surg
; 109(9): 800-803, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543289
5.
Corrigendum to: Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study.
Br J Surg
; 110(1): 124, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075875
6.
Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors.
Cancer Res
; 82(5): 819-830, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35027467
7.
Negative Pressure Wound Therapy Reduces Wound Breakdown and Implant Loss in Prepectoral Breast Reconstruction.
Plast Reconstr Surg Glob Open
; 8(2): e2667, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32309105
8.
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer.
J Oncol
; 2018: 2937012, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651729
9.
Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
Oncotarget
; 8(24): 38251-38263, 2017 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28418910
10.
PICan: An integromics framework for dynamic cancer biomarker discovery.
Mol Oncol
; 9(6): 1234-40, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814194
11.
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability.
Cancer Res
; 74(10): 2773-2784, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24638981
12.
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
Oncotarget
; 5(6): 1609-20, 2014 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24742492
13.
Academic medicine - revolution, evolution or extinction?
Ulster Med J
; 83(3): 141-5, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25484462